Allergy & Immunotherapy
Allergy & Immunotherapy
Requires Standards 1–7 verified first
3 criteria
| Standard 18.1 NON-NEGOTIABLE · Standard 18: Allergy & Immunotherapy Post-Injection Observation Time Is Enforced, Not Assumed |
ASSESSMENT ASF-AMB-STD18-v3.0 |
| CR N/A | TR FULL | SM FULL | ST FULL |
| 18.1 NON-NEGOTIABLE L1 |
THE STANDARD Post-Injection Observation Time Is Enforced, Not Assumed Every patient receiving an allergen immunotherapy injection is observed on-site for the minimum required period afterward, with this actually enforced — not left to the patient's own judgement about whether they feel well enough to leave early. |
| CLINIC SELF-ASSESSMENT Tick YES, PARTIAL, or NO for each question. |
| 1 | Is the minimum observation period actually enforced for every patient, not left to the patient's own judgement? Genuinely enforced, not a recommendation the patient can opt out of by feeling ready to leave. Doc: Observation enforcement protocol |
YES | PARTIAL | NO |
| 2 | Is the patient's departure time actually recorded and compared against injection time? A real, checkable record, not an assumption the full period was observed. Doc: Departure time tracking record |
YES | PARTIAL | NO |
| 3 | Is there a specific process for extending observation if symptoms develop during the standard window? A defined, known extension process, not uncertainty about what happens if something develops. Doc: Extended observation protocol |
YES | PARTIAL | NO |
ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.
| WHAT THE ASSESSOR DOES ON SITE no surprises, no hidden checks |
| OBSERVE Observation enforcement check |
Observes actual practice to confirm patients are genuinely held for the minimum period, not permitted to leave early. |
| DOCUMENT Departure time record review |
Reviews records comparing injection time against actual departure time for a sample of patients. |
| ASK Extended observation interview |
Asks staff what happens specifically if symptoms develop during the standard observation window. |
REFERENCES
- [83] Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55 — establishes a minimum post-injection observation period as a core safety requirement of allergen immunotherapy administration.
| Standard 18.1 · Standard 18: Allergy & Immunotherapy Guidance & Learning |
GUIDANCE ASF-AMB-STD18-v3.0 |
| WHY THIS STANDARD EXISTS |
Systemic allergic reactions to immunotherapy injections typically develop within the standard observation window, and the protection this window provides only works if the patient is actually still on-site and being watched when a reaction begins — not already on their way home because they felt fine leaving.
| WHAT GOOD LOOKS LIKE ✓ The minimum observation period is genuinely enforced for every patient. ✓ Departure time is recorded and verifiably matches or exceeds the required period. ✓ A specific, known process exists for extending observation when symptoms develop. |
WHAT FAILURE LOOKS LIKE ✗ Patients are permitted to leave early based on how they feel. ✗ No record exists comparing injection time against actual departure time. ✗ Staff are uncertain what happens if symptoms develop during observation. |
| MOST COMMON REASONS CLINICS SCORE PARTIAL |
1 Observation is enforced during busy periods when staff are actively monitoring the waiting area, but less consistently when the area is quiet.
The requirement doesn't depend on how busy the facility happens to be at the time.
2 Departure time is recorded but not actually compared against injection time to verify compliance.
A recorded time that's never checked against the requirement doesn't provide real verification.
3 Extension happens for obvious reactions but the threshold for what warrants extension isn't clearly defined.
A clear, specific threshold helps ensure consistent judgement across different staff members.
| HOW TO IMPLEMENT IF YOU ARE STARTING FROM ZERO |
Week 1 Review current observation practice for genuine enforcement, not patient-judgement-based departure.
Week 2 Establish a recorded departure time process, compared against injection time.
Week 3 Define and brief staff on a specific extended observation protocol.
Ongoing Audit departure time records against the minimum requirement periodically.
| FOR SURVEYORS — WHAT IS NOT OBVIOUS |
Ask to see actual departure time records compared against injection times for real patients.
Specific, dated records are the only real evidence the requirement is genuinely enforced.
Observe the waiting area during a quiet period specifically.
Enforcement is most likely to relax exactly when the area feels calm and unhurried.
| E-LEARNING academy.gmj.ge/amb-std18-1-observation-time — 30 min · complete before self-assessment |
| Standard 18.2 NON-NEGOTIABLE · Standard 18: Allergy & Immunotherapy Dose Escalation Follows a Defined, Individualized Schedule |
ASSESSMENT ASF-AMB-STD18-v3.0 |
| CR N/A | TR FULL | SM FULL | ST FULL |
| 18.2 NON-NEGOTIABLE L1 |
THE STANDARD Dose Escalation Follows a Defined, Individualized Schedule Immunotherapy dose escalation follows a defined schedule, individually adjusted for missed doses, prior reactions, and known risk factors — not advanced automatically according to a fixed calendar regardless of what actually happened at the previous visit. |
| CLINIC SELF-ASSESSMENT Tick YES, PARTIAL, or NO for each question. |
| 1 | Is dose escalation adjusted for missed doses, not advanced automatically as if the prior visit occurred on schedule? A specific, defined adjustment rule for missed doses, not automatic progression. Doc: Missed-dose adjustment protocol |
YES | PARTIAL | NO |
| 2 | Is dose escalation adjusted based on any reaction at the prior dose, not proceeding regardless? Genuine responsiveness to prior reaction history for this specific patient. Doc: Prior-reaction dose adjustment record |
YES | PARTIAL | NO |
| 3 | Is the current dose and escalation status verified before each injection, not assumed from the calendar? An active check against the patient's actual record, not assumed from how much time has passed. Doc: Pre-injection dose verification record |
YES | PARTIAL | NO |
ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.
| WHAT THE ASSESSOR DOES ON SITE no surprises, no hidden checks |
| DOCUMENT Missed-dose adjustment review |
Reviews records for evidence that missed doses trigger a defined adjustment, not automatic progression. |
| DOCUMENT Prior-reaction adjustment review |
Reviews whether a prior reaction genuinely changes the subsequent dose decision. |
| OBSERVE Pre-injection verification observation |
Observes whether dose and escalation status are actively verified against the patient's record before each injection. |
REFERENCES
- [84] Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55 — establishes dose adjustment for missed doses and prior reactions as a core safety requirement of immunotherapy dose escalation.
| Standard 18.2 · Standard 18: Allergy & Immunotherapy Guidance & Learning |
GUIDANCE ASF-AMB-STD18-v3.0 |
| WHY THIS STANDARD EXISTS |
Advancing an immunotherapy dose without accounting for a missed prior dose or an earlier reaction meaningfully increases systemic reaction risk — the schedule needs to reflect what actually happened for this specific patient, not proceed as if every visit occurred exactly on time with no complications.
| WHAT GOOD LOOKS LIKE ✓ Missed doses trigger a specific, defined adjustment to the escalation schedule. ✓ A prior reaction genuinely changes subsequent dose decisions. ✓ Dose and escalation status are actively verified against the record before each injection. |
WHAT FAILURE LOOKS LIKE ✗ Doses advance automatically according to a calendar regardless of missed visits. ✗ Prior reactions don't change subsequent dosing decisions. ✗ Dose is assumed from time elapsed rather than verified against the actual record. |
| MOST COMMON REASONS CLINICS SCORE PARTIAL |
1 Missed-dose adjustment happens for longer gaps but not shorter, still-relevant delays.
Even a shorter-than-expected gap can carry meaningful risk depending on the specific interval.
2 Prior reactions are noted in the record but don't consistently change the next dose decision.
A noted reaction that doesn't influence the subsequent decision doesn't provide the protection this criterion is meant to ensure.
3 Verification happens for new or unusual cases but becomes less rigorous for routine, long-established patients.
Established patients still benefit from the same active verification before each injection.
| HOW TO IMPLEMENT IF YOU ARE STARTING FROM ZERO |
Week 1 Review current escalation practice for genuine adjustment based on missed doses and prior reactions.
Week 2 Establish or reinforce a specific, defined missed-dose adjustment rule.
Week 3 Build active pre-injection verification into the standard workflow for every patient.
Ongoing Audit escalation decisions against missed-dose and prior-reaction adjustment rules.
| FOR SURVEYORS — WHAT IS NOT OBVIOUS |
Ask for a real example of a missed dose and how the schedule was adjusted.
A real example reveals whether adjustment is genuine practice, not just a stated policy.
Ask staff to verify a specific patient's current dose status directly from the record, not from memory.
This reveals whether verification is genuinely active, not assumed from familiarity with a long-standing patient.
| E-LEARNING academy.gmj.ge/amb-std18-2-dose-escalation — 30 min · complete before self-assessment |
| Standard 18.3 NON-NEGOTIABLE · Standard 18: Allergy & Immunotherapy Extract Preparation and Labeling Prevents Vial Mix-Up |
ASSESSMENT ASF-AMB-STD18-v3.0 |
| CR N/A | TR FULL | SM FULL | ST FULL |
| 18.3 NON-NEGOTIABLE L1 |
THE STANDARD Extract Preparation and Labeling Prevents Vial Mix-Up Allergen extract preparation, dilution, and labeling follows a defined, verified process specifically designed to prevent vial mix-up between patients — with a genuine, independent check before administration confirming the correct vial for the correct patient. |
| CLINIC SELF-ASSESSMENT Tick YES, PARTIAL, or NO for each question. |
| 1 | Is there a defined process for preparing and labeling extract vials that specifically prevents mix-up between patients? A specific, designed process, not general care assumed to be sufficient. Doc: Extract preparation and labeling protocol |
YES | PARTIAL | NO |
| 2 | Is there a genuine, independent check confirming the correct vial for the correct patient before administration, distinct from general patient identification? A specific vial-to-patient check, not folded into or assumed covered by general identification. Doc: Vial verification record |
YES | PARTIAL | NO |
| 3 | Are vials specifically labeled with concentration and patient identity in a way that's checked, not just present? Genuinely checked labeling, not assumed correct because a label exists. Doc: N/A — tested directly |
YES | PARTIAL | NO |
ALL YES Standard likely met. ANY PARTIAL Improvement plan required. ANY NO Blocks accreditation until resolved.
| WHAT THE ASSESSOR DOES ON SITE no surprises, no hidden checks |
| DOCUMENT Preparation and labeling protocol review |
Reviews the defined process for extract preparation and labeling specific to mix-up prevention. |
| OBSERVE Vial verification observation |
Observes an actual pre-administration check for genuine, independent vial-to-patient verification. |
| ASK Labeling practice interview |
Asks staff to describe how they confirm vial concentration and patient identity match before administering. |
REFERENCES
- [85] Correct extract and concentration verification, distinct from and in addition to general patient identification, is established practice for preventing vial mix-up in allergen immunotherapy administration.
| Standard 18.3 · Standard 18: Allergy & Immunotherapy Guidance & Learning |
GUIDANCE ASF-AMB-STD18-v3.0 |
| WHY THIS STANDARD EXISTS |
A vial mix-up between patients receiving different allergen extracts and concentrations is a serious, documented error type specific to immunotherapy practice, and the consequences of administering the wrong extract or the wrong concentration can be genuinely severe.
| WHAT GOOD LOOKS LIKE ✓ A specific, defined process prevents vial mix-up in preparation and labeling. ✓ A genuine, independent vial-to-patient check happens before every administration. ✓ Labeling is specifically checked, not just present. |
WHAT FAILURE LOOKS LIKE ✗ No specific mix-up prevention process exists beyond general care. ✗ Vial verification isn't genuinely independent or is folded loosely into general patient identification. ✗ Labels exist but aren't specifically checked before administration. |
| MOST COMMON REASONS CLINICS SCORE PARTIAL |
1 Verification is rigorous when a single patient is being seen but becomes less consistent during busy periods with multiple patients.
Mix-up risk is highest exactly when multiple vials for different patients are present simultaneously.
2 Labeling includes patient name but concentration isn't consistently double-checked.
Correct patient with incorrect concentration still represents a real, distinct risk.
3 The check happens but isn't genuinely independent — the same person prepares and verifies.
Independent verification requires a second person's genuinely separate confirmation.
| HOW TO IMPLEMENT IF YOU ARE STARTING FROM ZERO |
Week 1 Review current extract preparation and labeling practice for mix-up prevention specificity.
Week 2 Establish a genuine, independent vial-to-patient verification step before every administration.
Week 3 Reinforce labeling practice to include both patient identity and concentration, both checked.
Ongoing Observe verification practice periodically, particularly during busy periods with multiple patients.
| FOR SURVEYORS — WHAT IS NOT OBVIOUS |
Observe during a period when multiple patients are being seen for injections.
This is exactly when mix-up risk is highest and verification discipline most likely to be tested.
Ask whether the same person both prepares and verifies, or whether this is genuinely independent.
Genuine independence between preparation and verification is what distinguishes a real check from a formality.
| E-LEARNING academy.gmj.ge/amb-std18-3-extract-labeling — 30 min · complete before self-assessment |
Ambulatory Clinic Standards — overviewFacility Classification — Which Type of Facility Are You?Standard 1 — Access & ArrivalStandard 2 — Reception & InformationStandard 3 — Environment & Shared SpacesStandard 4 — Care & TreatmentStandard 5 — Safety & Emergency PreparednessStandard 6 — Aftercare & Follow-upStandard 7 — Governance & ManagementStandard 8 — Dental PracticeStandard 9 — Aesthetic & Injectable MedicineStandard 10 — Longevity & IV TherapyStandard 11 — Oncology & Infusion TherapyStandard 12 — Dialysis & Renal Replacement TherapyStandard 13 — Fertility & IVFStandard 14 — Cardiology & Cardiac CatheterizationStandard 15 — Ophthalmology & Day SurgeryStandard 16 — Diagnostic ImagingStandard 17 — DermatologyStandard 18 — Allergy & ImmunotherapyStandard 19 — Plastic & Cosmetic SurgeryStandard 20 — Psychiatry & Mental HealthStandard 21 — Narcology & Addiction TreatmentStandard 22 — Gastroenterology & EndoscopyStandard 23 — Pediatric Ambulatory CareStandard 24 — Medical TourismStandard 25 — Refugee & Migrant HealthReferences & Index
Test your facility against this standard
Open self-assessment — no login, no fee.
Print to share.
